» Articles » PMID: 34458737

Using Membrane Perturbing Small Molecules to Target Chronic Persistent Infections

Overview
Journal RSC Med Chem
Specialty Chemistry
Date 2021 Aug 30
PMID 34458737
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

After antibiotic treatment, a subpopulation of bacteria often remains and can lead to recalcitrant infections. This subpopulation, referred to as persisters, evades antibiotic treatment through numerous mechanisms such as decreased uptake of small molecules and slowed growth. Membrane perturbing small molecules have been shown to eradicate persisters as well as render these populations susceptible to antibiotic treatment. Chemotype similarities have emerged suggesting amphiphilic heteroaromatic compounds possess ideal properties to increase membrane fluidity and such molecules warrant further investigation as effective agents or potentiators against persister cells.

Citing Articles

The LiaSR Two-Component System Regulates Resistance to Chlorhexidine in .

Huang S, Huang J, Du J, Li Y, Wu M, Chen S Microorganisms. 2024; 12(3).

PMID: 38543519 PMC: 10972437. DOI: 10.3390/microorganisms12030468.


Efficacy of outer membrane permeabilization in promoting aromatic isothiocyanates-mediated eradication of multidrug resistant Gram-negative bacteria and bacterial persisters.

Lo C, Yeh T, Jao Y, Wang T, Lo H Folia Microbiol (Praha). 2024; 69(5):993-1002.

PMID: 38319459 DOI: 10.1007/s12223-024-01143-6.


Discovery of antibiotics that selectively kill metabolically dormant bacteria.

Zheng E, Valeri J, Andrews I, Krishnan A, Bandyopadhyay P, Anahtar M Cell Chem Biol. 2023; 31(4):712-728.e9.

PMID: 38029756 PMC: 11031330. DOI: 10.1016/j.chembiol.2023.10.026.


Isolation of Persister Cells of and Determination of Their Susceptibility to Antimicrobial Peptides.

Liu S, Brul S, Zaat S Int J Mol Sci. 2021; 22(18).

PMID: 34576222 PMC: 8470456. DOI: 10.3390/ijms221810059.

References
1.
Conery A, Larkins-Ford J, Ausubel F, Kirienko N . High-throughput screening for novel anti-infectives using a C. elegans pathogenesis model. Curr Protoc Chem Biol. 2014; 6(1):25-37. PMC: 4021578. DOI: 10.1002/9780470559277.ch130160. View

2.
McAuley S, Huynh A, Czarny T, Brown E, Nodwell J . Membrane activity profiling of small molecule growth inhibitors utilizing novel duel-dye fluorescence assay. Medchemcomm. 2018; 9(3):554-561. PMC: 6071753. DOI: 10.1039/c8md00009c. View

3.
Butler M, Blaskovich M, Cooper M . Antibiotics in the clinical pipeline at the end of 2015. J Antibiot (Tokyo). 2016; 70(1):3-24. DOI: 10.1038/ja.2016.72. View

4.
Vega N, Allison K, Khalil A, Collins J . Signaling-mediated bacterial persister formation. Nat Chem Biol. 2012; 8(5):431-3. PMC: 3329571. DOI: 10.1038/nchembio.915. View

5.
Moyed H, Bertrand K . hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J Bacteriol. 1983; 155(2):768-75. PMC: 217749. DOI: 10.1128/jb.155.2.768-775.1983. View